Financials Revenio Group Oyj

Equities

REG1V

FI0009010912

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki 11:29:42 2024-04-26 am EDT 5-day change 1st Jan Change
25.22 EUR +5.70% Intraday chart for Revenio Group Oyj +2.27% -7.14%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 695.4 1,334 1,476 1,026 722.3 670.7 - -
Enterprise Value (EV) 1 699.2 1,332 1,475 1,014 719.5 646.6 629.9 610.8
P/E ratio 144 x 99.8 x 85.2 x 47.2 x 37.8 x 32.6 x 24.8 x 20.7 x
Yield 1.14% 0.64% 0.61% 0.93% 1.4% 1.59% 1.89% 2.27%
Capitalization / Revenue 14 x 21.8 x 18.7 x 10.6 x 7.48 x 6.39 x 5.63 x 4.92 x
EV / Revenue 14.1 x 21.8 x 18.7 x 10.5 x 7.45 x 6.16 x 5.29 x 4.48 x
EV / EBITDA 47.9 x 61.4 x 55.9 x 30.6 x 23 x 20.2 x 15.7 x 12.9 x
EV / FCF -12.5 x 104 x 184 x 48.1 x 147 x 27.1 x 22.3 x 18.9 x
FCF Yield -7.98% 0.96% 0.54% 2.08% 0.68% 3.69% 4.49% 5.29%
Price to Book 10.8 x 19.3 x 18.9 x 11.3 x 7.26 x 6.09 x 5.29 x 4.57 x
Nbr of stocks (in thousands) 26,492 26,528 26,563 26,580 26,593 26,593 - -
Reference price 2 26.25 50.30 55.55 38.60 27.16 25.22 25.22 25.22
Announcement Date 2/20/20 2/11/21 2/10/22 2/9/23 2/15/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 49.5 61.1 78.8 97 96.6 105 119.2 136.3
EBITDA 1 14.6 21.7 26.4 33.1 31.3 32.08 40.11 47.24
EBIT 1 12.6 17.1 23.4 29.7 27.3 27.81 35.72 42.48
Operating Margin 25.45% 27.99% 29.7% 30.62% 28.26% 26.48% 29.97% 31.17%
Earnings before Tax (EBT) 1 12.3 16.7 22.1 29.1 25.4 26.8 34.87 42.37
Net income 1 9.3 13.4 17.3 21.8 19.1 20.63 27.04 32.54
Net margin 18.79% 21.93% 21.95% 22.47% 19.77% 19.64% 22.69% 23.88%
EPS 2 0.1825 0.5040 0.6520 0.8180 0.7190 0.7738 1.015 1.219
Free Cash Flow 1 -55.8 12.8 8 21.08 4.9 23.88 28.3 32.3
FCF margin -112.73% 20.95% 10.15% 21.74% 5.07% 22.73% 23.74% 23.7%
FCF Conversion (EBITDA) - 58.99% 30.3% 63.7% 15.65% 74.42% 70.56% 68.37%
FCF Conversion (Net income) - 95.52% 46.24% 96.72% 25.65% 115.72% 104.65% 99.26%
Dividend per Share 2 0.3000 0.3200 0.3400 0.3600 0.3800 0.4000 0.4760 0.5725
Announcement Date 2/20/20 2/11/21 2/10/22 2/9/23 2/15/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 23.8 20.2 24.4 24.1 28.3 23.2 22.3 22 29.1 23.6 24.07 24.93 32.1
EBITDA 1 8.6 6.4 8 8.5 10.2 7.1 5.6 7.2 10.5 6.2 7.04 7.5 11.2
EBIT 1 7.7 5.6 7.1 7.7 9.3 6.2 4.7 6.2 9.5 5.1 5.94 6.4 10.1
Operating Margin 32.35% 27.72% 29.1% 31.95% 32.86% 26.72% 21.08% 28.18% 32.65% 21.61% 24.68% 25.67% 31.46%
Earnings before Tax (EBT) 1 7.2 5.8 7 7.6 8.6 5.8 4.4 5.9 9.2 4.8 5.7 6.75 10.35
Net income 1 5.5 4.7 5.4 6 5.7 4.2 3.2 4.5 7.2 3.6 4.49 4.83 6.92
Net margin 23.11% 23.27% 22.13% 24.9% 20.14% 18.1% 14.35% 20.45% 24.74% 15.25% 18.66% 19.37% 21.56%
EPS 2 0.2060 0.1760 0.2030 0.2260 0.2140 0.1590 0.1220 0.1680 0.2700 0.1370 0.1700 0.1900 0.2933
Dividend per Share - - - - - - - - - - - - -
Announcement Date 2/10/22 4/28/22 8/4/22 10/27/22 2/9/23 4/27/23 8/10/23 10/26/23 2/15/24 4/25/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3.8 - - - - - - -
Net Cash position 1 - 1.9 0.79 11.9 2.8 24.1 40.7 59.9
Leverage (Debt/EBITDA) 0.2603 x - - - - - - -
Free Cash Flow 1 -55.8 12.8 8 21.1 4.9 23.9 28.3 32.3
ROE (net income / shareholders' equity) 22.7% 19.9% 23.4% 25.7% 20% 19.5% 22.4% 22.8%
ROA (Net income/ Total Assets) - 14.9% 14.5% 16.7% 14% 15.1% 18.8% 18.8%
Assets 1 - 89.95 119.5 130.6 136.8 136.4 144.1 173.4
Book Value Per Share 2 2.420 2.610 2.940 3.410 3.740 4.140 4.770 5.520
Cash Flow per Share 2 0.4900 0.4600 0.8100 0.8700 - 1.200 1.260 1.300
Capex 1 68.2 2.4 13.5 2.16 4.1 4.63 4.48 5.19
Capex / Sales 137.78% 3.93% 17.13% 2.22% 4.24% 4.41% 3.76% 3.81%
Announcement Date 2/20/20 2/11/21 2/10/22 2/9/23 2/15/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
25.22 EUR
Average target price
29.06 EUR
Spread / Average Target
+15.23%
Consensus
  1. Stock Market
  2. Equities
  3. REG1V Stock
  4. Financials Revenio Group Oyj